Bill > HCR002

This concurrent resolution directs the Public Employees' Benefit and Insurance Program (PEHP) to address pharmaceutical rebates in the state health plan by requiring PEHP to pass the estimated value of drug rebates directly to plan members at the point of sale, proportional to their cost-sharing responsibility. The resolution acknowledges that pharmaceutical rebates create a financial burden on patients with high-cost health conditions, who currently pay higher prices to subsidize rebates for other plan members. To ensure the change remains cost-neutral, the resolution suggests that the rebate costs can be spread across all covered state members through either increased member premiums or reduced health savings account contributions. Additionally, the resolution calls on PEHP to optimize its pharmacy benefit manager contract by continuously monitoring and updating the contract terms. The underlying context is to provide financial relief to state employees and their family members who require expensive medications by redistributing the current rebate system in a more equitable manner. The resolution highlights that the total cost of implementing this change would be approximately $2.84 per member per month.

Budget and Finance, Health and Social Services

https://le.utah.gov/~2025/bills/static/HCR002.html